Close Menu

NEW YORK — The Alzheimer's Drug Discovery Foundation (ADDF) said on Wednesday that it will provide as much as $1.9 million in funding to researchers from industry and academia advancing new diagnostic technologies for Alzheimer's disease.

ADDF said it has also partnered with Sage Bionetworks to establish an online repository for biomarker data generated by grant recipients, and that it has committed up to $1.3 million to support development of a mobile app for the early detection of memory problems.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.


This webinar will describe a rapid metagenomics assay under development for human pathogens, including the SARS-CoV-2 coronavirus.

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.


This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.